ExploreWatchlistsPricing
  1. US-listed companies
  2. Q BioMed Inc.
  3. Financials
  4. Operating expenses

Q BioMed Inc. (QBIO)

Market cap
$144.09
P/E ratio
SummaryFinancials
Period EndOperating expenses (Million USD)YoY (%)
Nov 30, 20223-53.16%
Nov 30, 20217-42.90%
Nov 30, 202013+60.22%
Nov 30, 20198-11.08%
Nov 30, 20189-27.09%
Nov 30, 201712+94.94%
Nov 30, 20166+16579.39%
Nov 30, 20140

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat